Insights into Argentavis magnificens (Aves, Teratornithidae) lifestyle based on neuroanatomy.

Teratornithidae is an extinct bird family, likely related to Cathartidae, known exclusively from the Americas. They were once thought to be scavengers, but recent theories suggest they were opportunistic or piscivorous birds capable of swallowing prey whole. The most notable species, Argentavis magnificens, had a wingspan of 6 to 8 m and weighed 70 to 80 kg.

[Cases of imported cholera in France, summer 2005. A. Tarantola for the incident management teams].

Cholera is a bacterial infection, which causes digestive symptoms and massive diarrhoea. It may lead to dehydration and death if appropriate medical management is not rapidly initiated. Most cases of infection by choleric vibrio, however, remain symptom-free or may mimic common gastroenteritis.

Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.

In a clinical trial on efficacy of Pentamidine in second stage Trypanosoma brucei gambiense patients with View Article and Find Full Text PDF

Availability and affordability of treatment for Human African Trypanosomiasis.

Human African Trypanosomiasis (HAT) is a re-emerging disease whose usual treatments are becoming less efficient because of the increasing parasite resistance. Availability of HAT drugs is poor and their production in danger because of technical, ecological and economic constraints. In view of this dramatic situation, a network involving experts from NGOs, WHO and pharmaceutical producers was commissioned with updating estimates of need for each HAT drug for the coming years; negotiations with potential producers of new drugs such as eflornithine; securing sustainable manufacturing of existing drugs; clinical research into new combinations of these drugs for first and second-line treatments; centralizing drug purchases and their distribution through a unique non-profit entity; and addressing regulatory and legal issues concerning new drugs.